Skip to content

Roivant Sciences Ltd.

ROIV· NasdaqCore metricsCIK 1635088

Pharmaceutical preparations552 peers

Last sale
Nov 12, 2026 · -4.49%
Market cap
$28.96B
724.56M shares
Filings
1,015
$35.12M
Q2 2026−71.6% FY25 yoy
-$191.62M
Q2 2026N/M FY25 yoy
-$268.05M
Q2 2026N/M FY25 yoy
$323.29M
Q2 2026derivedN/M FY25 yoy
-$0.27
Q2 2026N/M FY25 yoy
$1.64B
Q2 2026−47.7% FY25 yoy
$28.96B
—
704.9×
7.2×
-0.12%
—

Twelve months to Sep 30, 2026 · derived

Price

$39.97+91.15%+$19.06past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$8.26MFY 2025
$32.71M0FY 2021FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252026-03-31$8,260,000reported
FY 20242025-03-31$29,053,000reported
FY 20232024-03-31$32,713,000 revisedreported
FY 20222023-03-31$31,530,000 revisedreported
FY 20212021-03-31$23,795,000reported

Capital returns

Dividends and buybacks · FY2022 to FY2024
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2024—$1.29B$1.29B—679.81M sh−8.0%—
FY2023—$0.00$0.00—738.72M sh−2.8%—
FY2022—$0.00$0.00—760.14M sh+9.4%—

Segments

Products
Revenue by Products, FY2022 to FY2023FY2022Product revenue, net · FY2022 · $28.01MLicense, milestone and other revenue · FY2022 · $33.27MFY2023Product revenue, net · FY2023 · $75.06MLicense, milestone and other revenue · FY2023 · $49.74M
LineFY2023ShareChange
Product revenue, net$75.06M229%+168.0%
License, milestone and other revenue$49.74M152%+49.5%
Total$32.71M

From the 10-K filed May 30, 2024ROIV

Pharmaceutical preparations

Roivant Sciences Ltd. is the 175th largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Roivant Sciences Ltd. · CIK 1635088 · Engraved from SEC EDGAR